HRT Financial (CMND) adds 1.93M Clearmind Medicine shares in mixed trades

Filing Impact

(Moderate)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of Clearmind Medicine Inc., reported mixed trading in the company’s common stock. On June 10, it executed an open-market purchase of 2,159,052 shares at $0.153 per share. On June 11, it made an open-market sale of 225,191 shares at $0.123 per share. After these transactions, HRT Financial LP directly held 1,838,075 shares of Clearmind Medicine common stock, indicating it was a net buyer over the two days.

Insider Trade Summary

Net Buyer: 1,933,861 shares ($330,335)

Net Buy 2 txns

Insider HRT FINANCIAL LP

Role null

Bought 2,159,052 shs ($330K)

Sold 225,191 shs ($28K)

Type	Security	Shares	Price	Value
Sale	Common Stock	225,191	$0.123	$28K
Purchase	Common Stock	2,159,052	$0.153	$330K

Holdings After Transaction: Common Stock — 1,838,075 shares (Direct, null)

Footnotes (1)

Key Figures

Shares purchased: 2,159,052 shares Purchase price: $0.153/share Shares sold: 225,191 shares +3 more

6 metrics

Shares purchased 2,159,052 shares Open-market purchase of Common Stock on June 10

Purchase price $0.153/share Price for June 10 open-market purchase

Shares sold 225,191 shares Open-market sale of Common Stock on June 11

Sale price $0.123/share Price for June 11 open-market sale

Shares held after transactions 1,838,075 shares Direct holdings following June 11 sale

Net buy-sell shares 1,933,861 shares Net buy direction across reported transactions

Key Terms

open-market sale, open-market purchase, ten percent owner

3 terms

open-market sale financial

"transaction_action: "open-market sale" for 225,191 Common Stock shares"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

open-market purchase financial

"transaction_action: "open-market purchase" for 2,159,052 Common Stock shares"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner financial

"HRT FINANCIAL LP is marked as a ten percent owner of the issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:29 PM Accepted by SEC EDGAR 06/12/2026 - 04:28 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last)

(First)

(Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK

10007

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clearmind Medicine Inc. [ CMND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/10/2026		P		2,159,052	A	$0.153	2,063,266	D
Common Stock	06/11/2026		S		225,191	D	$0.123	1,838,075	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Adam Nunes	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did HRT Financial LP report in its Form 4 for Clearmind Medicine (CMND)?

HRT Financial LP reported both buying and selling Clearmind Medicine common stock. It purchased over 2.1 million shares on June 10 and sold about 225,000 shares on June 11, ending with 1,838,075 shares held directly.

How many Clearmind Medicine (CMND) shares did HRT Financial LP buy and at what price?

HRT Financial LP bought 2,159,052 Clearmind Medicine common shares in an open-market purchase on June 10. The reported purchase price was $0.153 per share, significantly increasing its direct position in the company’s stock over that day.

How many Clearmind Medicine (CMND) shares did HRT Financial LP sell and at what price?

HRT Financial LP sold 225,191 Clearmind Medicine common shares in an open-market sale on June 11. The reported sale price was $0.123 per share, a lower price than the prior day’s reported purchase price of $0.153 per share.

What is HRT Financial LP’s Clearmind Medicine (CMND) shareholding after these transactions?

Following the reported trades, HRT Financial LP directly holds 1,838,075 shares of Clearmind Medicine common stock. This figure comes from the Form 4 totals shown after the June 11 sale, reflecting its position immediately after the disclosed transactions.

Was HRT Financial LP a net buyer or seller of Clearmind Medicine (CMND) shares in this Form 4?

HRT Financial LP was a net buyer of Clearmind Medicine shares in the reported period. The Form 4 summary shows net buy-sell activity of 1,933,861 shares, indicating purchases materially exceeded sales across the two disclosed transactions.